Gynecologic Oncology Consult

Same-day discharge for hysterectomy


 

Management in the recovery room

Surgeons should ensure that recovery room staff are well versed in the pathway for patients who are selected for SDD to ensure proactive implementation of analgesic and antiemetic regimens and to fast-track the various tasks and education required for discharge.5

Patients should be started on their home postoperative medication regimen in the recovery room, including an anti-inflammatory such as diclofenac, sublingual tramadol (in preference to an opioid, such as hydrocodone), docusate, and sennosides. IV opioids should be avoided because they can result in somnolence and nausea.

If placed intraoperatively, the Foley catheter should be removed early to allow adequate time to void. Backfilling the bladder prior to removal can hasten the urge to void and help objectively document completeness of evacuation. All patients should be seen by the anesthesiologist and/or surgeon prior to discharge.

For patients who are discharged same day, a follow-up phone call on postoperative day 1 is valuable to ensure that they have continued their successful postoperative transition to the home and to intervene early if there are concerns for patient satisfaction.

Pages

Recommended Reading

Is pain or dependency driving elevated opioid use among long-term cancer survivors?
MDedge Internal Medicine
FDA approves biosimilar to bevacizumab
MDedge Internal Medicine
Missed opportunities abound to give HPV vaccine to adolescent girls
MDedge Internal Medicine
Adolescents with chronic health conditions often undervaccinated
MDedge Internal Medicine
FDA: Laparoscopic power morcellators can spread malignant cells when used in women with occult uterine cancers*
MDedge Internal Medicine
New multi-analyte blood test shows promise in screening for several common solid tumors
MDedge Internal Medicine
USPSTF: Routine screens for ovarian cancer not recommended
MDedge Internal Medicine
Telling her she has cancer: A patient-centered approach to breaking bad news
MDedge Internal Medicine
FDA authorizes first direct-to-consumer BRCA1/2 test
MDedge Internal Medicine
Chlamydia infections associated with more than a doubling of ovarian cancer risk
MDedge Internal Medicine